HORMONAL THERAPY IN CANCER OF THE BREAST. XXII. EFFECT OF 17ALPHA-METHYL-5BETA-DIHYDROTESTOSTERONE ON CLINICAL COURSE AND HORMONAL EXCRETION.
D015068:17-Ketosteroids; D000728:Androgens; D001940:Breast; D001943:Breast Neoplasms; D003401:Creatine; D003404:Creatinine; D003900:Desoxycorticosterone; D013196:Dihydrotestosterone; D006062:Gonadotropins; D006801:Humans; D007986:Luteinizing Hormone; D008207:Lymphatic Metastasis; D009369:Neoplasms; D011276:Pregnanediol; D011388:Prolactin; D014556:Urine
D015068:17-Ketosteroids; D000728:Androgens; D006062:Gonadotropins; D013196:Dihydrotestosterone; D003900:Desoxycorticosterone; D011388:Prolactin; D007986:Luteinizing Hormone; D003404:Creatinine; D011276:Pregnanediol; D003401:Creatine
17-KETOSTEROIDS; ANDROGENS; BREAST NEOPLASMS; CREATINE AND CREATININE; DESOXYCORTICOSTERONE; GONADOTROPINS; LH; LYMPHATIC METASTASIS; PREGNANEDIOL; PROLACTIN; URINE